Alle verbonden artikelen

Why balls are not put inside the basket? A reflection on testicular cancer clinical trial design.

Auteurs : Kourie HR, Aoun F
Jaar : 2016
Journal : Invest New Drugs
Volume : 34(4)
Pagina's : 513-4

A Belgian Survey on Geriatric Assessment in Oncology Focusing on Large-Scale Implementation and Related Barriers and Facilitators.

Auteurs : Kenis C, Heeren P, Decoster L, Van Puyvelde K, Conings G, Cornelis F, Cornette P, Moor R, Luce S, Libert Y, Van Rijswijk R, Jerusalem G, Rasschaert M, Langenaeken C, Baitar A, Specenier P, Geboers K, Vandenborre K, Debruyne PR, Vanoverbeke K, Van den Bulck H, Praet JP, Focan C, Verschaeve V, Nols N, Goeminne JC, Petit B, Lobelle JP, Flamaing J, Milisen K, Wildiers H
Jaar : 2016
Journal : J Nutr Health Aging
Volume : 20
Pagina's : 60-70

Levator Ani Necrosis: An Exceptional Complication Occurring after High Intensity Focused Ultrasound" of the Prostate."

Auteurs : Badawy D, El Rassy E, Aoun F, Van Velthoven R
Jaar : 2016
Journal : Case Rep Urol
Volume : 2016
Pagina's : 3920976

Efficacy of weekly paclitaxel treatment as a single agent chemotherapy following first-line cisplatin treatment in urothelial bladder cancer.

Auteurs : Sideris S, Aoun F, Zanaty M, Martinez NC, Latifyan S, Awada A, Gil T
Jaar : 2016
Journal : Mol Clin Oncol
Volume : 4
Pagina's : 1063-1067

Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial.

Auteurs : Piccart-Gebhart M, Holmes E, Baselga J, de Azambuja E, Dueck AC, Viale G, Zujewski JA, Goldhirsch A, Armour A, Pritchard KI, McCullough AE, Dolci S, Mcfadden E, Holmes AP, Tonghua L, Eidtmann H, Dinh P, Di Cosimo S, Harbeck N, Tjulandin S, Im YH, Huang CS, Diéras V, Hillman DW, Wolff AC, Jackisch C, Lang I, Untch M, Smith I, Boyle F, Xu B, Gomez H, Suter T, Gelber Rd, Perez EA
Jaar : 2016
Journal : J Clin Oncol
Volume : 34(10)
Pagina's : 1034-42

Vulnerabilities in Older Patients when Cancer Treatment is Initiated: Does a Cognitive Impairment Impact the Two-Year Survival?

Auteurs : Libert Y, Dubruille S, Borghgraef C, Etienne AM, Merckaert I, Paesmans M, Reynaert C, Roos M, Slachmuylder JL, Vandenbossche S, Bron D, Razavi D
Jaar : 2016
Journal : PLoS One
Volume : 11
Pagina's : e0159734

The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters.

Auteurs : Brouwers B, Hatse S, Dal Lago L, Neven P, Vuylsteke P, Dalmasso B, Debrock G, Van den Bulck H, Smeets A, Bechter O, Kini Bailur J, Kenis C, Laenen A, Schöffski P, Pawelec G, Journe F, Ghanem G, Wildiers H
Jaar : 2016
Journal : Oncotarget
Volume : 7(21)
Pagina's : 29977-88

Guidance for the prevention and treatment of venous thromboembolism in cancer patients

Auteurs : Awada A, Baurain JF, Clement P, Hainaut P, Holbrechts S, Hougardy JM, Jochmans K, Mathieu V, Mebis J, Strijbos MH, Vulsteke C, Verheij M
Jaar : 2016
Journal : Belgian J Medical Oncology
Volume : 7(6)
Pagina's : 217-23

Breast cancer in 2015: Academic research sheds light on issues that matter to patients.

Auteurs : Piccart-Gebhart M, Gingras I
Jaar : 2016
Journal : Nat Rev Clin Oncol
Volume : 13
Pagina's : 67-8

Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer : Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be th

Auteurs : Viale G, Slaets L, de Snoo FA, Bogaerts J, Russo L, van t Veer L, Rutgers E, Piccart-Gebhart M, Stork-Sloots L, Dell orto P, Glas A, Cardoso F
Jaar : 2016
Journal : Breast Cancer Res Treat
Volume : 155(3)
Pagina's : 463-9

Severe Prolonged Cough as Presenting Manifestation of FIP1L1-PDGFRA+ Chronic Eosinophilic Leukaemia: A Widely Ignored Association.

Auteurs : Roufosse F, Heimann P, Lambert F, Sidon P, Bron D, Cottin V, Cordier JF
Jaar : 2016
Journal : Respiration
Volume : 91
Pagina's : 374-9

Data on nitric oxide production by human bone marrow-derived mesenchymal stromal cells.

Auteurs : Najar M, Fayyad-Kazan M, Fayyad-Kazan H, Meuleman N, Bron D, Lagneaux L
Jaar : 2016
Journal : Data Brief
Volume : 8
Pagina's : 1111-4

Managing Hodgkin lymphoma without chemotherapy: a novel, yet 'welcomed', challenge.

Auteurs : Kourie HR, Tabchi S, Kattan J
Jaar : 2016
Journal : Future Oncol
Volume : 12(12)
Pagina's : 1435-7

The Future of Access to Innovative Medicines in Cancer Therapy: Towards Conditional Dialogue Fostering Affordable Therapeutic Innovation

Auteurs : van Dyk N, De Greve J, Schots R, Awada A, Van Eycken L, Geldof T
Jaar : 2016
Journal : Vlerick business school
Volume : 7
Pagina's : -

Reply to the letter to the editor 'The ESMO Magnitude of Clinical Benefit Scaling Tool: from theory to practice' by Hartmann and the letter 'Comment on ESMO Magnitude of Clinical Benefit Scale' by Muhonen et al.

Auteurs : Cherny NI, Sullivan R, Dafni U, Kerst JM, Sobrero A, Zielinski C, de Vries EGE, Piccart-Gebhart M
Jaar : 2016
Journal : Ann Oncol
Volume : 27
Pagina's : 205-207

Characterization of human breast cancer tissues by infrared imaging.

Auteurs : Verdonck M, Denayer A, Delvaux B, Garaud S, de Wind R, Desmedt C, Sotiriou C, Willard-Gallo K, Goormaghtigh E
Jaar : 2016
Journal : Analyst
Volume : 141(2)
Pagina's : 606-19

Catalog of genetic progression of human cancers: breast cancer.

Auteurs : Desmedt C, Yates L, Kulka J
Jaar : 2016
Journal : Cancer Metastasis Rev
Volume : 35(1)
Pagina's : 49-62

Unknown primary tumors: is there a future therapeutic role for immune checkpoint inhibitors?

Auteurs : Kourie HR, Awada G, Awada A
Jaar : 2016
Journal : Future Oncol
Volume : 12(4)
Pagina's : 429-31

Breast cancer genome and transcriptome integration implicates specific mutational signatures with immune cell infiltration.

Auteurs : Smid M, Rodríguez-González FG, Sieuwerts AM, Salgado R, Prager-Van der Smissen WJ, Vlugt-Daane MV, van Galen A, Nik-Zainal S, Staaf J, Brinkman AB, Van de Vijver MJ, Richardson AL, Fatima A, Berentsen K, Butler A, Martin S, Davies HR, Debets R, Gelder ME, van Deurzen CH, Macgrogan G, Van den Eynden GG, Purdie C, Thompson AM, Caldas C, Span PN, Simpson PT, Lakhani SR, Van Laere S, Desmedt C, Ringnér M, Tommasi S, Eyford J, Broeks A, Vincent-Salomon A, Futreal PA, Knappskog S, King T, Thomas G, Viari A, Langerød A, Børresen-Dale AL, Birney E, Stunnenberg HG, Stratton M, Foekens JA, Martens JW
Jaar : 2016
Journal : Nat Commun
Volume : 7
Pagina's : 12910

Loss of ARID1A activates ANXA1, which serves as a predictive biomarker for trastuzumab resistance.

Auteurs : Berns K, Sonnenblick A, Gennissen A, Brohée S, Hijmans ME, Evers B, Fumagalli D, Desmedt C, Loibl S, Denkert C, Neven P, Guo W, Zhang F, Knijnenburg TA, Bosse T, van der Heijden MS, Hindriksen S, Nijkamp W, Wessels LF, Joensuu H, Mills GB, Beijersbergen RL, Sotiriou C, Bernards R
Jaar : 2016
Journal : Clin Cancer Res
Volume : 22(21)
Pagina's : 5238-48